![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » TEVA NEUROSCIENCE ANNOUNCES AZILECT IS NOW AVAILABLE IN PHARMACIES
TEVA NEUROSCIENCE ANNOUNCES AZILECT IS NOW AVAILABLE IN PHARMACIES
July 31, 2006
Teva Neuroscience announced today the launch of AZILECT (rasagiline tablets),
the first, once-daily treatment for Parkinson's disease (PD) now available in
pharmacies by prescription only. This is important news for the majority (83%)
of respondents in a survey of those living with PD who report taking their PD
medications up to five times/day.
Yahoo
Finance
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct